Chicago Rivet & Machine (CVR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
3 Apr, 2026Executive summary
Annual Meeting scheduled for May 12, 2026, at Sheraton Lisle Hotel, Lisle, Illinois, with record date March 13, 2026.
Shareholders will vote on electing seven directors and ratifying Cherry Bekaert LLP as independent auditor for 2026.
Proxy materials and annual report for 2025 are available online; shareholders encouraged to vote by mail or electronically.
Voting matters and shareholder proposals
Proposals include election of seven director nominees and ratification of Cherry Bekaert LLP as auditor.
Shareholders may submit proposals for the 2027 meeting by December 4, 2026, and director nominations per bylaw requirements.
Universal proxy rules require notice by March 13, 2027, for alternative director nominees.
Board of directors and corporate governance
Board consists of seven directors, 86% independent, with an average age of 59 and significant board refreshment in the last five years.
Four standing committees: audit, compensation, executive, and nominating, all with written charters.
Nominating Committee considers shareholder-recommended candidates and values diversity, independence, and ethical conduct.
Board leadership includes a non-executive chairman; independent directors meet separately and rotate chairing sessions.
Latest events from Chicago Rivet & Machine
- Substantial doubt remains about going concern status despite improved margins and narrowed losses.CVR
Q4 202524 Mar 2026 - Shareholders will vote on director elections, executive pay, auditor ratification, and governance matters.CVR
Proxy Filing2 Dec 2025 - Returned to profitability in Q3 2025, but going concern risks persist amid industry challenges.CVR
Q3 20257 Nov 2025 - Q2 2024 returned to profit on improved margins, despite flat sales and ongoing risk from a product issue.CVR
Q2 202429 Sep 2025 - Sales fell 12.3% YoY in Q3 2024, with improved margins but a net loss of $1.45M.CVR
Q3 202429 Sep 2025 - Significant 2024 losses, liquidity risks, and operational restructuring amid industry headwinds.CVR
Q4 202429 Sep 2025 - Gross margin and net income improved despite lower sales, but liquidity risks persist.CVR
Q1 202529 Sep 2025 - Sales and margins declined in Q2 2025, raising going concern doubts despite cost actions.CVR
Q2 202529 Sep 2025